Skip to content

Clinical trials

Small Cell Lung Carcinoma trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Country / region: Austria Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20061
20071
20091
20111
20141
20163
20173
20181
20192
20201
20214
20224
20231
20243
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting10
Recruiting8
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen7
AbbVie3
GlaxoSmithKline3
Hoffmann-La Roche3
Merck Sharp & Dohme LLC3
Bristol-Myers Squibb2
PharmaMar2
Advanced Accelerator Applications1
AstraZeneca1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma37
Carcinoma, Non-Small-Cell Lung5
Neoplasms4
Lung Neoplasms3
Breast Neoplasms2
Carcinoma, Hepatocellular2
Bites and Stings1
Carcinoma, Merkel Cell1
Carcinoma, Transitional Cell1
Cholangiocarcinoma1

Trials

Showing 26 to 37 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.